| Category |
Product Name |
CAS No. |
Usage |
| Anti-virus |
(2S, 5R)-5-Fluoro cytosine-1-yl-[1,3]-oxathiolane-2-carboxylic acid menthyl ester (FCME) |
147126-75-8 |
Intermediate of Emtricitabine [143491-57-0] |
| Antibiotic |
S-2-Benzothiazolyl (Z) -2-(2-aminothiazol-4-yl)-2-acetyloxyiminothioacetate (CAEM) |
104797-47-9 |
Intermediate of Cefdinir [91832-40-5] |
| Antihypertensive |
(2-n-Butyl-5-chloro-imidazole-4-yl)-carboxaldehyde (BCFI) |
83857-96-9 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Anti-virus |
(2R, 3S)-N-Boc-3-amino-1, 2-epoxy-4-Phenylbutane (Boc Epoxy) |
98760-08-8 |
Intermediate of Atazanavir [198904-31-3] |
| Anti-virus |
(2R, 5R)-5-Hydroxy-[1,3]-oxathiolane-2-carboxylic acid menthyl ester (HME) |
147126-62-3 |
Intermediate of Emtricitabine [143491-57-0] |
| Antibiotic |
(2S,3S)-3-amino-2-methyl-4-oxo-1-azetidinesulfonic acid |
80082-65-1 |
Intermediate of Aztreonam [78110-38-0] |
| Anti-virus |
(2S.5R)-5-Cytosine-1-yl-[1,3]-oxathiolane -2-carboxylic acid menthyl ester (CME) |
147027-10-9 |
Intermediate of Lamivudine [134678-17-4] |
| Anti-virus |
(5-Thiazolyl)methyl-(4-nitrophenyl) carbonate |
144163-97-3 |
Intermediate of Ritonavir [155213-67-5 ] and Lopinavir [192725-17-0] |
| Antibiotic |
(Benzothiazol-2-yl)-(Z)-2-Methoxyimino-2-(2-Amino-thiozol-4-yl)Thioacetate (MAEM) |
80756-85-0 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| Antibiotic |
(Benzothiazol-2-yl)-(Z)-2-Trityimino-2-(2-Aminothiazol-4-yl)Thioac etate |
143183-03-3 |
Intermediate of Cefdinir [91832-40-5] |
| Antibiotic |
(R) -2-[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonylamino]-2-(4-hydroxyphenyl)acetic acid (OH-EPCP) |
62893-24-7 |
Intermediate of Cefoperazone [62893-19-0] and cefoperazone sodium [62893-20-3] |
| Anti-virus |
(R)-9-(2-phosphonylmethoxy propyl) adenine (R-PMPA) |
206184-49-8 |
Intermediate of Tenofovir [147127-20-6] and Adefovir [106941-25-7] |
| Antihypertensive |
(S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinoline carboxylic acid benzyl ester p-toluenesulfonate salt |
82586-59-2 |
Intermediate of Moexipril HCL [1033775-10-6] |
| Migraine |
(S)-4-(4-Amido Phenyl)-1,3-Oxazolidin-2-One |
152305-23-2 |
Intermediate of Zolmitriptan [139264-17-8] |
| Antihypertensive |
(s,s)-2-azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride |
93779-29-4 |
Intermediates of Ramipril [87333-19-5] |
| Antihypertensive |
(s,s,s)-2-azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride |
93779-31-8 |
Intermediate of Ramipril [87333-19-5] |
| Anti-virus |
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
156732-13-7 |
Intermediate of Ritonavir [155213-67-5 ] and Lopinavir [192725-17-0] |
| Antibiotic |
(Z) -4-Chloro-2-methoxyimino-3-oxobutanoic acid (CMOA) |
111230-59-2 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1], Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] And Cefodizime [69739-16-8], Cefodizime Sodium [86329-79-5] |
| Antibiotic |
(Z)-2-(2-Aminothiazol-4-yl)-2-(l-Carboxy-l-Methyl)Ethoxyimino Acetic Acid (ATCA) |
102507-85-7 |
Intermediate of Ceftazidime [78439-06-2] |
| Antibiotic |
(Z)-2-(2-Aminothiazol-4-yl)-2-(t-Butoxycarbonylmethoxyimino)Acetic Acid (ATTMA) |
74440-02-1 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
(Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetic acid (ATAIA) |
110130-88-6 |
Intermediate of cefdinir [91832-40-5] |
| Antibiotic |
(Z)-2-(2-Aminothiazol-4-yl)-2-Carboxymethoxyimino Acetic Acid (ATCMA) |
74440-05-4 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
(Z)-2-(2-Aminothiazol-4-yl)-2-methoxycarbonylmethoxyiminoacetic acid (MICA) |
80544-17-8 |
Intermediate of cefixime [79350-37-1] and carumonam [87638-04-8] |
| Antibiotic |
(Z)-2-(2-aminothiazol-4-yl)-2-pentenoic acid (ATPA) |
118109-49-2 |
Intermediate of cefcapene pivoxil hydrochloride [147816-24-8] and cefcapene pivoxil [105889-45-0] |
| Antibiotic |
(Z)-2-(2-Aminothiazol-4-yl)-2-Trityloxyimino Acetic Acid (ATOA) |
128438-01-7 |
Intermediate of Cefdinir [91832-40-5] |
| Antibiotic |
(Z)-2-(2-Formylaminothiazol-4-yl)-2-Methoxyimino Acetic Acid (FTMA) |
65872-43-7 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| Antibiotic |
(Z)-2-(2--t-Butoxycarbonylaminothiazol-4-yl)-2-Pentenoic Acid (BTPA) |
86978-24-7 |
Intermediate of Cefcapene pivoxil hydrochloride [147816-24-8] and Cefcapene pivoxil [105889-45-0] |
| Antibiotic |
(Z)-2-(2-tert-Butoxycarbonylprop-2-Oxyimino)-2-(2-Amino-thiazol-4-yl)Acetic Acid (AT-TBA) |
86299-47-0 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| Antibiotic |
(Z)-2-(2-Tritylaminothiazol-4-yl)-2-Methoxyimino Acetic Acid (TTMA) |
64485-90-1 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| Antibiotic |
(Z)-2-(2-Tritylaminothiazol-4-yl)-2-trityloxyiminoacetic acid (TTOA) |
68786-47-0 |
Intermediate of cefdinir [91832-40-5] |
| Antibiotic |
(Z)-2-(5-Amino-1,2,4-Thiadiazol-3-yl)-2-Methoxyimino Acetic Acid (ATDA) |
72217-12-0 |
Intermediate of Cefozopran [113359-04-9] and Cefozopran hydrochloride [113981-44-5] |
| Antibiotic |
(Z)-2-(Methoxycarbonyl Methoxyimino)-2-(2-Aminothiazol-4-yl)Acetic Acid (MICA) |
80554-17-8 |
Intermediate of Cefixime [79350-37-1] |
| Antibiotic |
(Z)-2-(tert-Butoxycarbonylprop-2-Oxyimino)-2-(2-Tritylamino-thiazol-4-yl)Acetic Acid (TB-TAA) |
68672-66-2 |
Intermediate of Ceftazidime [78439-06-2] |
| Antibiotic |
(Z)-2-Hydroxyimino-2-(2-Aminothiazol-4-yl)Acetic Acid (HATA) |
66338-96-3 |
Intermediate of Cefdinir [91832-40-5], Ceftazidime [78439-06-2] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| Antibiotic |
(Z)-2-Methoxyimino-2-(2-Aminothiazol-4-yl)Acetic Acid Anhydrous (AMAA) |
65872-41-5 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| Antibiotic |
(Z)-2-Methoxyimino-2-(Furyl-2-yl)Acetic Ammonium Salt (SMIA) |
97148-39-5 |
Intermediate of Cefuroxime [55268-75-2] and Cefuroxime Sodium [56238-63-2] |
| Diabetes |
[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]carbamic acid ethyl ester |
318515-70-7 |
Intermediate of Glimepiride [93479-97-1] |
| Antihypertensive |
[5-(1-Hydroxyl-1-methylethyl)-2-propyl-imidazol-4-yl] carboxylic acid ethyl ester |
144689-93-0 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antihypertensive |
1-(1,4-Benzodioxane-2-carbonyl)piperazine |
70918-00-2 |
Intermediate of Doxazosin Mesylate [77883-43-3] |
| Antitumor |
1, 2, 3-Tri-O-acetyl-5-deoxy-beta-D-ribofuranose |
62211-93-2 |
Intermediate of Capecitabine [154361-50-9] |
| Antiepileptic |
10-Methoxy Iminostilbene (10-MISB) |
4698-11-7 |
Intermediate of Oxcarbazepine [28721-07-5] |
| Dementia |
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)-piperidine |
120014-07-5 |
Intermediate of Donepezil HCL [120011-70-3] |
| Dementia |
1-Benzyl-4-Piperidine carboxaldehyde |
22065-85-6 |
Intermediate of Donepezil HCL [120011-70-3] |
| Antihypertensive |
1-chloroethyl chlorofomate |
50893-53-3 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antihypertensive |
1-chloroethyl cyclohexyl carbonate |
99464-83-2 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antibiotic |
1-Methyl-5-Mercapto-1,2,3,4-Tetrazole (MMTZ) |
13183-79-4 |
Intermediate of Cefamandole [34444-01-4], Cefamandole Sodium [30034-03-8] and Cefoperazone [62893-19-0], Cefoperazone Sodium [62893-20-3] |
| Antibiotic |
2-(2-Aminothiazol-4-yl)Acetic Acid (ATAA) |
29676-71-9 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| Antibiotic |
2-(2-Aminothiazol-4-yl)Acetic Acid Hydrochloride (ATAH) |
66659-20-9 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| Antibiotic |
2-(2-Aminothiazol-4-yl)Glyoxylic Acid (ATGA) |
73150-67-1 |
Intermediate of Cephalothins |
| Antibiotic |
2-(2-Formylaminothiazol-4-yl)Acetic Acid (FTAA) |
75890-68-5 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| Antibiotic |
2-(2-Formylaminothiazol-4-yl)Glyoxylic Acid (FTGA) |
64987-06-0 |
Intermediate of Cephalothins |
| Antihypertensive |
2-(2-Methoxy phenoxy)-ethylamine hydrochloride |
64464-07-9 |
Intermediate of Carvedilol [72956-09-3] |
| Cardiovascular |
2-(3, 4-Dimethoxyphenyl)-3-methylbutyronitrile |
20850-49-1 |
Intermediate of Verapamil [52-53-9] |
| Diabetes |
2-(5-Ethyl-2-pyridyl)ethanol |
5223-06-3 |
Intermediate of Pioglitazone HCL [112529-15-4] |
| Antitumor |
2', 3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
Intermediate of Capecitabine [154361-50-9] |
| Anti-virus |
2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone (DDQ) |
84-58-2 |
Intermediate of Others (Anti-AIDS) |
| Anti-virus |
2,3-Dicyanohydroquinone |
|
Intermediate of Others (Anti-AIDS) |
| Anti-Epiphyte |
2,4-Dihydro-4-[4-[4-(4-Hydroxylphenyl)Piperazin-l-yl]Phenyl]-2-(l-Methylpropyl)-3H-1,2,4-Triazol-3-One (DHMT) |
106461-41-0 |
Intermediate of Itraconazole [84625-61-6] |
| Antibiotic |
2,5-Dihydro-6-Hydroxy-3-Mercapto-2-Methyl-5-Oxo-1,2,4-Triazine (TTZ) |
58909-39-0 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] |
| Analgesic |
2-[(P-bromomethyl) phenyl] propionic acid |
111128-12-2 |
Intermediate of Loxoprofen sodium [80382-23-6] |
| Digestive System |
2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole |
103577-40-8 |
Intermediate of Lansoprazole [103577-45-3] |
| Diabetes |
2-[N-Methyl-N-(2-pyridinyl)amino] ethanol |
122321-04-4 |
Intermediate of Rosiglitazone [122320-73-4] |
| Antibiotic |
205307-52-4 |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate (PAIA) |
Intermediate of Cefdinir [91832-40-5] |
| Ophthalmology |
2-Acetylamino-5-mercapto-1,3,4-thiadiazole (AMTD) |
32873-56-6 |
Intermediate of Acetazolamide [59-66-5] |
| Ophthalmology |
2-Amino-5-Mercapto-1,3,4-Thiadiazol (AMTD) |
2349-67-9 |
Intermediate of Acetazolamide [59-66-5] |
| Antibiotic |
2-Aminooxy-2-Methylpropanoic Acid Hydrochloride (AOIBA) |
89766-91-6 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| Analgesic |
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate |
249561-98-6 |
Intermediate of Etoricoxib [202409-33-4] |
| Digestive System |
2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride |
127337-60-4 |
Intermediate of Lansoprazole [103577-45-3] |
| Antihypertensive |
2-Cyano-4'-bromomethylbiphenyl |
114772-54-2 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antihypertensive |
2-Cyano-4'-Methyl Biphenyl |
114772-53-1 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antibiotic |
2-Mercapto-1,3,4-Thiadiazol (MTD) |
18686-82-3 |
Intermediate of Ceftezole [26973-24-0] and Ceftezole Sodium [41136-22-5] |
| Antibiotic |
2-Mercapto-4-Methyl-5-Thiazoleacetic Acid (MMTA) |
34272-64-5 |
Intermediate of Cefodizime [69739-16-8] and Cefodizime sodium [86329-79-5] |
| Antibiotic |
2-Mercapto-5-methyl-1,3,4-thiadiazole (MMTD) |
29490-19-5 |
Intermediate of Cefazolin [25953-19-9] and Cefazolin Sodium [27164-46-1] |
| Antihypertensive |
2-N-butyl-4-spiro-cyclopentane-2-imidazoline 5 one HCl |
151257-01-1 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antihypertensive |
2-n-Propyl-4-methyl-6-(1'-methylbenzimidazol-2'-yl)benzimidazole |
152628-02-9 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Digestive System |
3-(2-Guanidino-thiazol-4-yl-methylthio)-propionitrile |
76823-93-3 |
Intermediate of Famotidine [76824-35-6] |
| Antitumor |
3,5-Di-O-benzoyl-2-deoxy-2, 2-difluoro-D-erythropentane-1, 4-lactone |
122111-01-7 |
Intermediate of Gemcitabine [95058-81-4] |
| Antidepressive |
3'-Chloropropiophenone |
34841-35-5 |
Intermediate of Bupropion HCl [31677-93-7] |
| Diabetes |
3-ethyl-4-methyl-2-oxo-3-pyrroline-2-one |
766-36-9 |
Intermediate of Glimepiride [93479-97-1] |
| Antibiotic |
3-Hydroxy-5-Mercapto-4-Isothiazolecarboxylic Acid Monosodium Salt (HMIM) |
475112-25-5 |
Intermediate of Cefotetan [69712-56-7] and Cefotetan Disodium [74356-00-6] |
| Antibiotic |
3-Hydroxy-5-mercapto-4-isothiazolecarboxylic acid trisodium salt (HMIT) |
76857-14-2 |
Intermediate of Cefotetan [69712-56-7] and Cefotetan Disodium [74356-00-6] |
| Antibiotic |
3-thienylpropanedioic acid (TPA) |
21080-92-2 |
Intermediate of Ticarcillin [34787-01-4] and Ticarcillin Sodium [4697-14-7] |
| Antihypertensive |
4-(2, 3-Epoxypropoxy)-carbazole |
51997-51-4 |
Intermediate of Carvedilol [72956-09-3] |
| Cardiovascular |
4, 5, 6, 7-tetrahydro thieno [3,2-c] pyridine hydrochloride |
28783-41-7 |
Intermediate of Clopidogrel [113665-84-2] |
| Diabetes |
4-[2-(3-ethyl-4-methyl-2-oxo-pyrroline-1-carboxamido)-ethyl]]Benzene sulfonamide |
119018-29-0 |
Intermediate of Glimepiride [93479-97-1] |
| Diabetes |
4-[2-(methyl-2-pyridinyl)amino]ethoxyl nitrobenzene |
329249-47-0 |
Intermediate of Rosiglitazone [122320-73-4] |
| Diabetes |
4-2-(5-ethyl-2-pyridinyl)ethoxy nitrobenzene |
85583-54-6 |
Intermediate of Pioglitazone HCL [112529-15-4] |
| Analgesic |
4-Bromo-2-fluorobiphenyl |
41604-19-7 |
Intermediate of Flurbiprofen [5104-49-4] |
| Antihypertensive |
4-Bromomethyl-2'-(2-trityl-2H-tetrazol-5-yl)biphenyl (TTBB) |
124750-51-2 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antibiotic |
4-Chioro-2-(Z)-Methoxycarbonyl Methoxyimino-3-Oxobutyric Acid (CMOBA) |
95759-10-7 |
Intermediate of Cefixime [79350-37-1] |
| Migraine |
4-Dimethylaminobutyraldebyde Diethyl Acetal |
1116-77-4 |
Intermediate of Zolmitriptan [139264-17-8] |
| Cardiovascular |
4-Hydroxycarbazole |
52602-39-8 |
Intermediate of corvedilol [72956-09-3] |
| Analgesic |
4-Methylsulfonyl acetophenone |
10297-73-1 |
Intermediate of Etoricoxib [202409-33-4] |
| Analgesic |
4-Methylsulphonylphenylacetic acid |
90536-66-6 |
Intermediate of Etoricoxib [202409-33-4] |
| Digestive System |
4-Nitro-2,3-lutidine-N-oxide |
37699-43-7 |
Intermediate of Lansoprazole [103577-45-3] |
| Dementia |
4-pyridine carboxaldehyde |
872-85-5 |
Intermediate of Donepezil HCL [120011-70-3] |
| Antihypertensive |
5-(4'-Bromomethyl-biphenyl-2-yl)-2-trityl-2H-tetrazole |
|
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Dementia |
5,6-dimethoxy-1-indanone |
2107-69-9 |
Intermediate of Donepezil HCL [120011-70-3] |
| Dementia |
5,6-Dimethoxy-2-(4-pyridylmethylene)-l-indanone |
4803-74-1 |
Intermediate of Donepezil HCL [120011-70-3] |
| Dementia |
5,6-Dimethoxy-2-(piperidin-4-yl)methyl-indan-1-one |
120014-30-4 |
Intermediate of Donepezil HCL [120011-70-3] |
| Prostate |
5-[(2R)-2Aminopropyl]-2-methoxy benzene sulfonamide |
112101-81-2 |
Intermediate of Tamsulosin [106133-20-4] |
| Diabetes |
5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione |
122320-73-4 |
Intermediate of Rosiglitazone [122320-73-4] |
| Diabetes |
5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione |
122320-74-5 |
Intermediate of Rosiglitazone [122320-73-4] |
| Diabetes |
5-{4-[2-(5-Ethyl-2-pyridinyl)ethoxyl]benzyldene}-2,4-thiazolidinedione |
144809-28-9 |
Intermediate of Pioglitazone HCL [112529-15-4] |
| Diabetes |
5-{4-[2-(5-Ethyl-2-pyridyl) ethoxy] benzyl}-2,4- thiazolidinedione |
105390-47-4 |
Intermediate of Pioglitazone HCL [112529-15-4] |
| Diabetes |
5-{4-[2-(5-Ethyl-2-pyridyl) ethoxy] benzyl}-2-imino-4-thiazolidinone |
105355-26-8 |
Intermediate of Pioglitazone HCL [112529-15-4] |
| Diabetes |
5-{4-[2-(methyl-pyridin-2-yl-amino)-ethoxy]benzyl}-2-imino-4-thiazolidinone |
329249-53-8 |
Intermediate of Rosiglitazone [122320-73-4] |
| Diabetes |
5-Chlorosalicylic Acid |
321-14-2 |
Intermediate of Glibenclamide [10238-21-8] |
| Anti-virus |
5-Flucytosine |
2022-85-7 |
Intermediate of Emtricitabine [143491-57-0] |
| Antibiotic |
5-Mercapto-1,2,3,4-Tetrazole-1-Methyl Sulfonic Acid Di-sodium Salts (SMT-DS) |
66242-82-8 |
Intermediate of Cefonicid [61270-58-4] Cefonicid Sodium [61270-78-8] |
| Anti-virus |
5'-Trityl-2'-deoxy-2,3'-didehydrothymidine |
25442-42-6 |
Intermediate of Zidovudine [30516-87-1] |
| Antibiotic |
7-ANCA |
36923-17-8 |
Intermediate of Cephalothins |
| Antibiotic |
7-AVCA |
79349-82-9 |
Intermediate of Cephalothins |
| Cardiovascular |
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid |
86393-33-1 |
Intermediate of cinnarizine [298-57-7] |
| Analgesic |
7-Ethyltryptophol |
41340-36-7 |
Intermediate of Etodolac [41340-25-4] |
| Antibiotic |
7-MAC |
56610-72-1 |
Intermediate of Cephalothins |
| Anti-virus |
9-(4-Acetoxy-3-Acetoxymethylbut-1-Yl)-2-Amino-6-Chloropurine |
97845-60-8 |
Intermediate of Famciclovir [104227-87-4] |
| Digestive System |
Amidinothiourea |
2114-02-5 |
Intermediate of Famotidine [76824-35-6] |
| Anti-virus |
Aminocarbinol [(1s.Cis)-4-amino-2-cyclopentene-1-methanol] |
136522-35-5 |
Intermediate of Abacavir [136470-78-5] |
| Antibiotic |
Benzothiazol-2-yl-(Z)-2-(tert-Butoxycarbonylprop-2-Oxyimino)-(2-Aminothiazol-4-yl)Thioacetate (BPTA) |
89604-92-2 |
Intermediate of Ceftazidime [78439-06-2] |
| Antihypertensive |
butyl (3s)3-amino-2,3,4,5-tetrahydro-1h-[1]benzazepin-2-one-1-acetate |
109010-30-8 |
Intermediate of Benazepril [86541-74-4] |
| Anti-virus |
CBZ L-Valine / (2-Amido-1,6-Dihydro-6-Oxy-9h-9-Methoxy) Ethyl-N-(Benzyloxy Carboxy)-L-Valine Ester |
1149-26-4 |
Intermediate of Valaciclovir HCL [124832-27-5] |
| Cardiovascular |
Cis(+)Hydroxy Lactum |
42399-49-5 |
Intermediate of Diltiazem HCL [33286-22-5] |
| Anti-Epiphyte |
Cis-[2-(2,4-Dichlorophenyl)-2-(1,2,4-Triazol-1-yl-Methyl)-1,3-Dioxolan-4-yl]Methyl Methanesulphonate (CIS-TCSF) |
67914-86-7 |
Intermediate of Itraconazole [84625-61-6] |
| Anti-Epiphyte |
Cis-[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-Dioxolan-4-yl]Methyl-4- Methlbenzenesulphonate (CIS-TOSYLATE) |
154003-23-3 |
Intermediate of Itraconazole [84625-61-6] |
| Anti-Epiphyte |
Cis-[2-Bromomethyl-2-(2,4-Dichlorophenyl)-1,3-Dioxolan-4-yl]Methyl Benzoate (CIS-BROMOBENZOATE) |
61397-56-6 |
Intermediate of Itraconazole [84625-61-6] |
| Anti-virus |
Cytosine |
71-30-7 |
Intermediate of Lamivudine [134678-17-4] |
| Antihypertensive |
ECPPA / n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanine |
82717-96-2 |
Intermediate of Enalapril Maleate [76095-16-4] |
| Antihypertensive |
ECPPA Na / n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl carboxy anhydride |
84793-24-8 |
Intermediate of Enalapril Maleate [76095-16-4] |
| Antihypertensive |
Ethyl [2-ethoxy-1-[(2¡¯-cyanobiphenyl-4-yl)methyl]benzimidazol-7-yl] carboxylate |
139481-41-7 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Antibiotic |
Ethyl 2-(2-Aminothiazol-4-yl)Acetate (EATA) |
53266-94-7 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| Antibiotic |
Ethyl 2-(2-formylaminothiazol-4-yl) acetate (EFTA) |
64987-05-9 |
Intermediate of cefotiam [61622-34-2] and cefotiam hydrochloride [66309-69-1] |
| Antibiotic |
Ethyl(Z)-2-(2-Aminothiazol-4-yl)-2-(l-t-Butoxycarbonyl-l-Methyl)Ethoxyimino Acetate (EATB) |
86299-46-9 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| Antibiotic |
Ethyl(Z)-2-(2-Aminothiazol-4-yl)-2-Methoxyiminoacetate (EATM) |
64485-88-7 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1], Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] and Cefodizime [69739-16-8], Cefodizime sodium [86329-79-5] |
| Antibiotic |
Ethyl(Z)-2-Hydroxyimino-2-(2-Aminothiazol-4-yl)Acetate (EHATA) |
64485-82-1 |
Intermediate of Cefdinir [91832-40-5] and Ceftazidime [78439-06-2] |
| Antibiotic |
Ethyl-2-(2-Aminothiazol-4-yl)-2-Oxo-Acetate (EAOA) |
64987-08-2 |
Intermediate of Cephalothins |
| Antibiotic |
Ethyl-2-(2-Formylaminothiazol-4-yl)Glyoxylate (EFTG) |
64987-03-7 |
Intermediate of Cephalothins |
| Antitumor |
Ethyl2, 2-difluoro-3-hydroxy-3-(2, 2-dimethyl-1, 3- dioxalan-4-yl) propionate |
95058-92-7 |
Intermediate of Gemcitabine [95058-81-4] |
| Antihypertensive |
Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate |
136285-67-1 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Analgesic |
Etodolac methyl ester |
122188-02-7 |
Intermediate of Etodolac [41340-25-4] |
| Antiepileptic |
Iminodibenzyl |
494-19-9 |
Intermediate of Carbamazepine [298-46-4] |
| Antiepileptic |
Iminodibenzyl Carbonyl Chloride |
33948-19-5 |
Intermediate of Carbamazepine [298-46-4] |
| Antiepileptic |
Iminostilbene Carbonyl Chloride |
33948-22-0 |
Intermediate of Carbamazepine [298-46-4] |
| Antibiotic |
L-(-)-¦Á-Hydroxy-¦Ã-Amino Butyric Acid (HABA) |
40371-51-5 |
Intermediate of Amikacin [37517-28-5] and Amikacin Sulfate [39831-55-5] |
| Antibiotic |
L-(-)-¦Á-Hydroxy-¦Ã-Benzyloxycarbonylamino Butyric Acid (CBZ-HABA) |
40371-50-4 |
Amikacin [37517-28-5] and Amikacin Sulfate [39831-55-5] |
| Anti-virus |
Lamivudine salicylate |
173522-96-8 |
Intermediate of Lamivudine [134678-17-4] |
| Anti-virus |
L-Menthyl glyoxylate hydrate |
111969-64-3 |
Intermediate of Lamivudine [134678-17-4] |
| Analgesic |
Loxoprofen acid |
68767-14-6 |
Intermediate of Loxoprofen sodium [80382-23-6] |
| Antihypertensive |
Methyl 2-acetylamino-3-chloropropionate |
18635-38-6 |
Intermediate of Ramipril [87333-19-5] |
| Antihypertensive |
Methyl 4'-bromomethyl biphenyl-2-carboxylate |
114772-38-2 |
Intermediate of Telmisartan [144701-48-4] |
| Diabetes |
Methyl-2-bromo-3-{4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl} propionate |
105355-25-7 |
Intermediate of Pioglitazone HCL [112529-15-4] |
| Analgesic |
Methyl-2-oxocyclopentane carboxylate |
10472-24-9 |
Intermediate of Loxoprofen sodium [80382-23-6] |
| Anti-virus |
Methylcarbonyl-L-t-leucine |
162537-11-3 |
Intermediate of Atazanavir [198904-31-3] |
| Anti-virus |
N-(2-amino-4.6-dichloro-5-pyrimdinyl) formamide |
171887-03-9 |
Intermediate of Abacavir [136470-78-5] |
| Antihypertensive |
N-[(2'-cyano(1.1'-biphenyl)-4-yl)methyl]methylester]-l-valine hydrochloride |
137863-89-9 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
| Anti-virus |
N-{[N-methyl-N-[(2-isopropyl-4-thiazolyl) methyl]-N-methyl]amino}carbony-L-valine |
154212-61-0 |
Intermediate of Ritonavir [155213-67-5 ] and Lopinavir [192725-17-0] |
| Antihypertensive |
n-6-trifluoro acetyl-l-lysine |
10009-20-8 |
Intermediate of Lisinopril Dihydrate [83915-83-7] |
| Antihypertensive |
N-acethyl-3-chloro-l-serine methyl ester |
87333-22-0 |
Intermediates of Ramipril [87333-19-5] |
| Antihypertensive |
N-Methyl-1,2-benzenediamine dihydrochloride |
25148-68-9 |
Intermediate of Telmisartan [144701-48-4] |
| Cardiovascular |
N-Methyl-2-(3,4-dimethoxyphenyl)ethylamine |
3490-06-0 |
Intermediate of Verapamil [52-53-9] |
| Antibiotic |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-(1-t-butoxycarbonyl-1-methyl) ethoxyiminoacetate (PABA) |
179258-52-7 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| Antibiotic |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-(t-butoxycarbonylmethoxyimino) acetate (PTMA) |
204185-34-2 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-methoxycarbonylmethoxyiminoace-tate (PMMA) |
C12H18N3O8PS |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetate (PAMA) |
179258-53-8 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| Antibiotic |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-trityloxyiminoacetate (PAOA) |
193402-47-0 |
Intermediate of Cefdinir [91832-40-5] |
| Antibiotic |
O,O-Diethylphosphoryl (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetate (PATD) |
C9H15N4O6PS |
Intermediate of Cefozopran [113359-04-9] and Cefozopran Hydrochloride [113981-44-5] |
| Antibiotic |
O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-(t-butoxycarbonylmethoxyimino) acetate (DTMA) |
524925-11-9 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate (DAIA) |
200815-01-6 |
Intermediate of Cefdinir [91832-40-5] |
| Antibiotic |
O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-methoxycarbonylmethoxyi-minoacetate (DMMA) |
C18H12N3O7PS2 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-trityloxyiminoacetate (DAOA) |
200814-98-8 |
Intermediate of Cefdinir [91832-40-5] |
| Antibiotic |
O,O-Diethylthiophosphoryl (Z)- 2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino acetate (DATD) |
C9H15N4O5PS2 |
Intermediate of Cefozopran [113359-04-9] |
| Antibiotic |
O,O-Diethylthiophosphoryl(Z)-2-(2-Aminothiazol-4-yl)-2-(l-t-Butoxycarbonyl-l-Methyl)Ethoxyiminoacetate (DABA) |
162208-28-8 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| Anti-virus |
R-(+)-Propylene carbonate |
16606-55-6 |
Intermediate of Tenofovir [147127-20-6] and Adefovir [106941-25-7] |
| Cardiovascular |
S-(+)-2-chlorophenyl glycine methyl ester hydrochloride |
141109-14-0 |
Intermediate of Clopidogrel [113665-84-2] |
| Cardiovascular |
S-(+)-Methyl-(2-chlorophenyl)[(2-(2-thienyl)amino] acetate hydrochloride |
141109-19-5 |
Intermediate of Clopidogrel [113665-84-2] |
| Antibiotic |
S-2-Benzothiazolyl (Z)-2-(2-aminothiazol-4-yl)-2-(t-butoxycarbonylmethoxyimino) thioacetate (DAEM) |
89605-09-4 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Antibiotic |
S-2-Benzothiazolyl (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino thioacetate (ZAEM) |
89604-91-1 |
Intermediate of Cefozopran [113359-04-9] and Cefozopran hydrochloride [113981-44-5] |
| Antibiotic |
S-2-Benzothiazolyl(Z)-2-(2-Aminothiazol-4-yl)-2-Methoxycarbonylmethoxyiminothioacetate (FAEM) |
246035-38-1 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| Anti-virus |
T-butyl-2-[4-(pyridin-2-yl)benzyl] hydrazine carboxylate |
198904-85-7 |
Intermediate of Atazanavir [198904-31-3] |
| Antihypertensive |
Trans-4-cyclohexyl-l-proline |
103201-78-1 |
Intermediate of Fosinopril [98048-97-6] |
| Diabetes |
Trans-4-methyl cyclohexyl amine |
6321-23-9 |
Intermediate of Glimepiride [93479-97-1] |
| Diabetes |
Trans-4-methyl cyclohexyl isocyanate |
32175-00-1 |
Intermediate of Glimepiride [93479-97-1] |
| Antihypertensive |
Trityl irbesartan |
138402-10-5 |
Intermediate Irbesartan[138402-11-6] |
| Antihypertensive |
Trityl losartan |
133909-99-6 |
Intermediate of Losartan[114798-26-4] |
| Antihypertensive |
Trityl valsartan |
195435-23-5 |
Intermediate of Valsartan[137862-53-4] |
| Digestive System |
Vanadyl acetylacetonate |
3153-26-2 |
Intermediate of Lansoprazole [103577-45-3] |
| Anti-virus |
¦Â-Thymidine |
50-89-5 |
Intermediate of Zidovudine [30516-87-1] |
